WO2002086663A3 - Computer system fro providing information about the risk of an atypical clinical event based upon genetic information - Google Patents

Computer system fro providing information about the risk of an atypical clinical event based upon genetic information Download PDF

Info

Publication number
WO2002086663A3
WO2002086663A3 PCT/US2002/012153 US0212153W WO02086663A3 WO 2002086663 A3 WO2002086663 A3 WO 2002086663A3 US 0212153 W US0212153 W US 0212153W WO 02086663 A3 WO02086663 A3 WO 02086663A3
Authority
WO
WIPO (PCT)
Prior art keywords
information
computer system
clinical event
risk
atypical clinical
Prior art date
Application number
PCT/US2002/012153
Other languages
French (fr)
Other versions
WO2002086663A2 (en
Inventor
Mark A Hoffman
David P Mccallie Jr
Original Assignee
Cerner Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cerner Corp filed Critical Cerner Corp
Priority to CA2444717A priority Critical patent/CA2444717C/en
Priority to EP02731406A priority patent/EP1388033A4/en
Priority to AU2002303386A priority patent/AU2002303386B8/en
Publication of WO2002086663A2 publication Critical patent/WO2002086663A2/en
Publication of WO2002086663A3 publication Critical patent/WO2002086663A3/en

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G16B50/20—Heterogeneous data integration
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H80/00—ICT specially adapted for facilitating communication between medical practitioners or patients, e.g. for collaborative diagnosis, therapy or health monitoring

Abstract

A method in a computer system for preventing atypical clinical events related to information identified by DNA testing a person is provided. The method includes receiving clinical agent information. The method also includes determining if a gene is associated with the clinical agent information, and if so, obtaining a genetic test result value for the associated gene of the person. The method further includes comparing the genetic test result value to a list of polymorphism values associated with an atypical clinical event, and determining whether the genetic test result value correlates to a polymorphism value on the list, and if so, outputting information about the atypical clinical event associated with the polymorphism value.
PCT/US2002/012153 2001-04-20 2002-04-18 Computer system fro providing information about the risk of an atypical clinical event based upon genetic information WO2002086663A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA2444717A CA2444717C (en) 2001-04-20 2002-04-18 Computer system for providing information about the risk of an atypical clinical event based upon genetic information
EP02731406A EP1388033A4 (en) 2001-04-20 2002-04-18 Computer system fro providing information about the risk of an atypical clinical event based upon genetic information
AU2002303386A AU2002303386B8 (en) 2001-04-20 2002-04-18 Computer system for providing information about the risk of an atypical clinical event based upon genetic information

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US28526301P 2001-04-20 2001-04-20
US60/285,263 2001-04-20
US09/981,248 2001-10-16
US09/981,248 US20020187483A1 (en) 2001-04-20 2001-10-16 Computer system for providing information about the risk of an atypical clinical event based upon genetic information

Publications (2)

Publication Number Publication Date
WO2002086663A2 WO2002086663A2 (en) 2002-10-31
WO2002086663A3 true WO2002086663A3 (en) 2003-05-22

Family

ID=26963099

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/012153 WO2002086663A2 (en) 2001-04-20 2002-04-18 Computer system fro providing information about the risk of an atypical clinical event based upon genetic information

Country Status (5)

Country Link
US (4) US20020187483A1 (en)
EP (1) EP1388033A4 (en)
AU (2) AU2002303386B8 (en)
CA (2) CA2444717C (en)
WO (1) WO2002086663A2 (en)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998029790A2 (en) * 1996-12-30 1998-07-09 Imd Soft Ltd. Medical information system
US7433827B2 (en) * 1999-06-23 2008-10-07 Visicu, Inc. System and method for displaying a health status of hospitalized patients
US7256708B2 (en) * 1999-06-23 2007-08-14 Visicu, Inc. Telecommunications network for remote patient monitoring
US7395216B2 (en) 1999-06-23 2008-07-01 Visicu, Inc. Using predictive models to continuously update a treatment plan for a patient in a health care location
US7454360B2 (en) 1999-06-23 2008-11-18 Visicu, Inc. Order evaluation system for use in a healthcare location
US7454359B2 (en) 1999-06-23 2008-11-18 Visicu, Inc. System and method for displaying a health status of hospitalized patients
US7411509B2 (en) * 1999-06-23 2008-08-12 Visicu, Inc. System and method for observing patients in geographically dispersed health care locations
US7467094B2 (en) * 1999-06-23 2008-12-16 Visicu, Inc. System and method for accounting and billing patients in a hospital environment
US7321862B2 (en) * 1999-06-23 2008-01-22 Visicu, Inc. System and method for patient-worn monitoring of patients in geographically dispersed health care locations
US7991625B2 (en) * 1999-06-23 2011-08-02 Koninklijke Philips Electronics N.V. System for providing expert care to a basic care medical facility from a remote location
US7315825B2 (en) * 1999-06-23 2008-01-01 Visicu, Inc. Rules-based patient care system for use in healthcare locations
US7475019B2 (en) * 1999-11-18 2009-01-06 Visicu, Inc. System and method for physician note creation and management
US8175895B2 (en) * 1999-06-23 2012-05-08 Koninklijke Philips Electronics N.V. Remote command center for patient monitoring
US7650291B2 (en) * 1999-06-23 2010-01-19 Koninklijke Philips Electronics N.V. Video visitation system and method for a health care location
US7542961B2 (en) * 2001-05-02 2009-06-02 Victor Gogolak Method and system for analyzing drug adverse effects
US8438042B2 (en) * 2002-04-25 2013-05-07 National Biomedical Research Foundation Instruments and methods for obtaining informed consent to genetic tests
US20030040002A1 (en) * 2001-08-08 2003-02-27 Ledley Fred David Method for providing current assessments of genetic risk
US7461006B2 (en) * 2001-08-29 2008-12-02 Victor Gogolak Method and system for the analysis and association of patient-specific and population-based genomic data with drug safety adverse event data
US7848935B2 (en) 2003-01-31 2010-12-07 I.M.D. Soft Ltd. Medical information event manager
US8620678B2 (en) 2003-01-31 2013-12-31 Imd Soft Ltd. Medical information query system
US8688385B2 (en) * 2003-02-20 2014-04-01 Mayo Foundation For Medical Education And Research Methods for selecting initial doses of psychotropic medications based on a CYP2D6 genotype
ES2575903T3 (en) 2003-02-20 2016-07-04 Mayo Foundation For Medical Education And Research Methods to select antidepressant medications
US8095379B2 (en) * 2003-12-30 2012-01-10 Cerner Innovation, Inc. System and method for preemptive determination of the potential for an atypical clinical event related to the administering of medication
WO2005067375A2 (en) * 2004-01-09 2005-07-28 Imd-Soft, Ltd. Clinical data database system and method for a critical care and/or hospital environment
EP1603069A1 (en) * 2004-06-04 2005-12-07 Hiromasa Kurita Information service system based on genetic character
US20060136143A1 (en) * 2004-12-17 2006-06-22 General Electric Company Personalized genetic-based analysis of medical conditions
US20060136267A1 (en) * 2004-12-22 2006-06-22 Cemer Innovation, Inc. System and method for automatic scheduling based on remote monitoring
ES2529211T3 (en) * 2005-11-29 2015-02-18 Children's Hospital Medical Center Optimization and individualization of medication selection and dosage
WO2007067956A2 (en) * 2005-12-07 2007-06-14 The Trustees Of Columbia University In The City Of New York System and method for multiple-factor selection
US8489409B2 (en) * 2006-04-27 2013-07-16 Cerner Innovation, Inc. Automated newborn screening results reporting
US20070294103A1 (en) * 2006-06-14 2007-12-20 Cerner Innovation, Inc. Automated laboratory test ordering and result tracking
GB2444410B (en) * 2006-11-30 2011-08-24 Navigenics Inc Genetic analysis systems and methods
US20080131887A1 (en) 2006-11-30 2008-06-05 Stephan Dietrich A Genetic Analysis Systems and Methods
US8099298B2 (en) 2007-02-14 2012-01-17 Genelex, Inc Genetic data analysis and database tools
JP2009049662A (en) * 2007-08-17 2009-03-05 Toshiba Corp Information processor
CN101978073B (en) * 2008-01-25 2014-12-10 诊疗实验室 Methods and compositions for the assessment of drug response
US8303694B2 (en) * 2008-05-27 2012-11-06 Perkinelmer Health Sciences, Inc. Chromatography systems and methods using them
US8600777B2 (en) 2008-08-28 2013-12-03 I.M.D. Soft Ltd. Monitoring patient conditions
JP5750043B2 (en) * 2008-10-20 2015-07-15 エピトム ファーマシューティカルズ リミテッド Method and system for improved pharmaceutical intervention in coagulation control
WO2010111222A1 (en) * 2009-03-24 2010-09-30 Perkinelmer Health Sciences, Inc. Sorbent devices with longitudinal diffusion paths and methods of using them
EP2425240A4 (en) 2009-04-30 2012-12-12 Good Start Genetics Inc Methods and compositions for evaluating genetic markers
US8388736B2 (en) * 2009-10-02 2013-03-05 Perkinelmer Health Sciences, Inc. Sorbent devices and methods of using them
US20110082867A1 (en) * 2009-10-06 2011-04-07 NeX Step, Inc. System, method, and computer program product for analyzing drug interactions
DE102010013114B4 (en) * 2010-03-26 2012-02-16 Rüdiger Lawaczeck Prediagnostic safety system
CN203786091U (en) 2010-06-14 2014-08-20 魄金莱默保健科学有限公司 System and device for modulating flow of fluid in chromatographic system
US20120016594A1 (en) * 2010-07-02 2012-01-19 Coriell Institute For Medical Research, Inc. Method for translating genetic information for use in pharmacogenomic molecular diagnostics and personalized medicine research
US9163281B2 (en) 2010-12-23 2015-10-20 Good Start Genetics, Inc. Methods for maintaining the integrity and identification of a nucleic acid template in a multiplex sequencing reaction
JP2014511159A (en) 2011-03-10 2014-05-12 テヴァ ファーマスーティカル インダストリーズ エルティーディー． Methods, systems, and programs for improved health care
US9228233B2 (en) 2011-10-17 2016-01-05 Good Start Genetics, Inc. Analysis methods
US8209130B1 (en) 2012-04-04 2012-06-26 Good Start Genetics, Inc. Sequence assembly
US10227635B2 (en) 2012-04-16 2019-03-12 Molecular Loop Biosolutions, Llc Capture reactions
US10210312B2 (en) 2013-02-03 2019-02-19 Youscript Inc. Systems and methods for quantification and presentation of medical risk arising from unknown factors
US8778609B1 (en) 2013-03-14 2014-07-15 Good Start Genetics, Inc. Methods for analyzing nucleic acids
US10851414B2 (en) 2013-10-18 2020-12-01 Good Start Genetics, Inc. Methods for determining carrier status
US11053548B2 (en) 2014-05-12 2021-07-06 Good Start Genetics, Inc. Methods for detecting aneuploidy
WO2016040446A1 (en) 2014-09-10 2016-03-17 Good Start Genetics, Inc. Methods for selectively suppressing non-target sequences
US10429399B2 (en) 2014-09-24 2019-10-01 Good Start Genetics, Inc. Process control for increased robustness of genetic assays
EP4095261A1 (en) 2015-01-06 2022-11-30 Molecular Loop Biosciences, Inc. Screening for structural variants
US10395759B2 (en) 2015-05-18 2019-08-27 Regeneron Pharmaceuticals, Inc. Methods and systems for copy number variant detection
US20170076047A1 (en) * 2015-09-16 2017-03-16 Good Start Genetics, Inc. Systems and methods for genetic testing
US10950354B1 (en) 2018-03-02 2021-03-16 Allscripts Software, Llc Computing system for pharmacogenomics
US11527331B2 (en) * 2018-06-15 2022-12-13 Xact Laboratories, LLC System and method for determining the effectiveness of medications using genetics
US11227685B2 (en) * 2018-06-15 2022-01-18 Xact Laboratories, LLC System and method for laboratory-based authorization of genetic testing
US11380424B2 (en) 2018-06-15 2022-07-05 Xact Laboratories Llc System and method for genetic based efficacy testing
US11398312B2 (en) 2018-06-15 2022-07-26 Xact Laboratories, LLC Preventing the fill of ineffective or under-effective medications through integration of genetic efficacy testing results with legacy electronic patient records
CN113539395A (en) * 2021-06-22 2021-10-22 首都医科大学附属北京安贞医院 Method and system for risk control of pharmaceutical clinical trial projects

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6315720B1 (en) * 2000-10-23 2001-11-13 Celgene Corporation Methods for delivering a drug to a patient while avoiding the occurrence of an adverse side effect known or suspected of being caused by the drug
US20020012921A1 (en) * 2000-01-21 2002-01-31 Stanton Vincent P. Identification of genetic components of drug response
US20020049772A1 (en) * 2000-05-26 2002-04-25 Hugh Rienhoff Computer program product for genetically characterizing an individual for evaluation using genetic and phenotypic variation over a wide area network
EP1211627A1 (en) * 2000-11-03 2002-06-05 TheraSTrat AG Method and system for registration, identifying and processing of drug specific data

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994015219A1 (en) * 1992-12-23 1994-07-07 Board Of Regents Of The University Of Nebraska Method for automatic testing of laboratory specimens
US5833599A (en) * 1993-12-13 1998-11-10 Multum Information Services Providing patient-specific drug information
US5758095A (en) * 1995-02-24 1998-05-26 Albaum; David Interactive medication ordering system
US5750345A (en) * 1995-10-31 1998-05-12 Evanston Hospital Corporation Detection of human α-thalassemia mutations and their use as predictors of blood-related disorders
US6112182A (en) * 1996-01-16 2000-08-29 Healthcare Computer Corporation Method and apparatus for integrated management of pharmaceutical and healthcare services
US5950630A (en) * 1996-12-12 1999-09-14 Portwood; Michael T. System and method for improving compliance of a medical regimen
US6112185A (en) * 1997-06-30 2000-08-29 Walker Digital, Llc Automated service upgrade offer acceptance system
JP3176342B2 (en) * 1997-08-13 2001-06-18 ファイザー製薬株式会社 Method for evaluating drug metabolism and reagent composition for said method
US6122182A (en) * 1998-03-12 2000-09-19 Moisin; Mihail Direct AC to AC power conversion apparatus for controlling power delivered to a load
JP2002510817A (en) * 1998-04-03 2002-04-09 トライアングル・ファーマシューティカルズ，インコーポレイテッド System, method and computer program product for guiding treatment prescription plan selection
US6067524A (en) * 1999-01-07 2000-05-23 Catalina Marketing International, Inc. Method and system for automatically generating advisory information for pharmacy patients along with normally transmitted data
US6219674B1 (en) * 1999-11-24 2001-04-17 Classen Immunotherapies, Inc. System for creating and managing proprietary product data
US7509263B1 (en) * 2000-01-20 2009-03-24 Epocrates, Inc. Method and system for providing current industry specific data to physicians
US20020038227A1 (en) * 2000-02-25 2002-03-28 Fey Christopher T. Method for centralized health data management
US20020052761A1 (en) * 2000-05-11 2002-05-02 Fey Christopher T. Method and system for genetic screening data collection, analysis, report generation and access
US6931326B1 (en) * 2000-06-26 2005-08-16 Genaissance Pharmaceuticals, Inc. Methods for obtaining and using haplotype data
EP1366185B9 (en) * 2000-07-11 2007-10-17 Kirk Hogan Methods and compositions for perioperative genomic profiling
WO2002017770A2 (en) * 2000-08-28 2002-03-07 Morand Patrick G Use of blood and plasma donor samples and data in the drug discovery process
US20030113727A1 (en) * 2000-12-06 2003-06-19 Girn Kanwaljit Singh Family history based genetic screening method and apparatus
US7756722B2 (en) * 2001-02-01 2010-07-13 Georgetown University Clinical management system from chronic illnesses using telecommunication
AU2002363329A1 (en) * 2001-11-06 2003-05-19 Elizabeth Gray Pharmacogenomics-based system for clinical applications

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020012921A1 (en) * 2000-01-21 2002-01-31 Stanton Vincent P. Identification of genetic components of drug response
US20020049772A1 (en) * 2000-05-26 2002-04-25 Hugh Rienhoff Computer program product for genetically characterizing an individual for evaluation using genetic and phenotypic variation over a wide area network
US6315720B1 (en) * 2000-10-23 2001-11-13 Celgene Corporation Methods for delivering a drug to a patient while avoiding the occurrence of an adverse side effect known or suspected of being caused by the drug
EP1211627A1 (en) * 2000-11-03 2002-06-05 TheraSTrat AG Method and system for registration, identifying and processing of drug specific data

Also Published As

Publication number Publication date
US20040197813A1 (en) 2004-10-07
AU2002303386B2 (en) 2008-05-29
CA2444717A1 (en) 2002-10-31
WO2002086663A2 (en) 2002-10-31
CA2977605A1 (en) 2002-10-31
US20170213011A1 (en) 2017-07-27
AU2002303386B8 (en) 2008-06-26
US20040199333A1 (en) 2004-10-07
US20020187483A1 (en) 2002-12-12
EP1388033A2 (en) 2004-02-11
AU2008207426A1 (en) 2008-09-11
CA2444717C (en) 2017-10-31
AU2008207426B2 (en) 2010-08-19
EP1388033A4 (en) 2008-07-09

Similar Documents

Publication Publication Date Title
WO2002086663A3 (en) Computer system fro providing information about the risk of an atypical clinical event based upon genetic information
WO2001001218A3 (en) Methods for obtaining and using haplotype data
WO2006019828A3 (en) System and method for providing and utilizing presence information
US11703516B2 (en) Method and apparatus for detecting target substances using gradient determination
WO2004044688A3 (en) Customer relationship management system and method for physical locations
EP1314677A3 (en) Managing method and system for building equipment and elevator
WO2002061659A3 (en) Computer-assisted means for assessing lifestyle risk factors
WO2002091232A3 (en) Method, system, and program for querying data in a personal information manager database
WO2003040987A3 (en) Patient data mining for lung cancer screening
WO2003009198A3 (en) Biometric system and method for identifying a customer upon entering a retail establishment
WO2000004187A3 (en) Methods and kits for diagnosing and determination of the predisposition of diseases
GB0319251D0 (en) System and method for selecting data providers
WO2004046098A3 (en) Method for predicting autoimmune diseases
RU2008125130A (en) SYSTEM AND METHOD FOR DELIVERY OF INFORMATION FOR MOBILE DEVICES
WO2004044817A3 (en) System and method for assessing the functional ability or medical condition of an actor
WO2008042232A3 (en) Method and system for displaying genetic and genealogical data
WO2005013177A3 (en) Methods, systems, and apparatus for monitoring within-day energy balance deviation
WO2007020598A3 (en) Method and apparatus featuring simple click style interactions according to a clinical task workflow
WO2006057675A3 (en) Method and system for automated risk management of rule-based security
JP2000275163A5 (en) Particle analyzer and automatic particle analysis method
WO2008042220A3 (en) User interface and identification in a medical device system and method
WO2006015340A3 (en) Medical records system and method
WO2005017695A3 (en) Information about structural integrity of vehicles
HUP0004415A2 (en) Detection systems for registering protein interactions and functional relationships
WO2002041234A3 (en) System and method for selectively classifying a population

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2444717

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002303386

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2002731406

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002731406

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP